• 尊龙凯时



  • Welcome to Hubei Haosun Pharmaceutical Co.,Ltd.
    Home| Order | Contact us
    News

    Pass EDQM audit

    Audit time: on July 11 to 13, 2016

    After three days of EDQM audit, our five API products Docetaxel anhydrous, Amisulpride, Granisetron HCl, Flumazenil and Oxaliplatin approved by EDQM.